Pfizer in final stages of agreement to supply vaccine doses to India, says CEO Albert Bourla

Pfizer, he said, is confident of producing three billion doses of COVID-19 vaccines and another four billion by next year

June 22, 2021 08:13 pm | Updated 08:13 pm IST - Washington

A vial of the Pfizer/BioNTech vaccine. File

A vial of the Pfizer/BioNTech vaccine. File

US Pharma giant Pfizer is in the final stages of an agreement with India to supply anti-COVID-19 vaccines, CEO Dr Albert Bourla said on Tuesday, observing that the domestically manufactured vaccines would be the backbone of vaccinating the Indian people.

Addressing the 15th edition of the India-US Bio Pharma & Healthcare Summit being organised by the US-India Chamber of Commerce, Dr Bourla also said that Pfizer has made a specific plan that the mid and low-income countries, which includes India, will receive at least two billion of such doses.

“My hope is that very soon we will finalise the approval of the product in India by the Indian health care authorities and the agreement with the government so that we can also start sending vaccines, on our side,” Dr. Bourla said.

The Pfizer CEO said that a significant local manufacturing of vaccines that is happening at the Serum Institute of India will provide the “backbone of vaccinating” the Indian people.

“But getting the additional mRNA vaccines from us and also from Moderna will contribute significantly,” he said.

Pfizer, he said, is confident of producing three billion doses of COVID-19 vaccines and another four billion by next year, making it seven billion in all.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.